JAZZ Venture Partners — 2023 Investments

2 investments dated 2023 · listed companies and verified rows first · show all

Cadence Neurosciencecadenceneuro.com inMay 2023 · $26M✓ verified

Cadence develops a neuromodulation system intended to be a more effective, less invasive treatment for people living with drug-refractory epilepsy.

BiotechDigital HealthHealthtechMedical DevicesSammamish, US

Kent Leyde(Executive Officer, Director, Promoter)Warren Douglas Sheffield(Executive Officer, Director, Promoter)

Co-investorsLumira Ventures Angelini Ventures F-Prime Capital Iaso Ventures

Tomato AI inAug 2023Acquired

Leverages generative AI to improve human speech, initially focused on international customer support agents.

Danville, US

Ofer Ronen(Executive Officer, Director, Promoter)Ye Jia(Executive Officer, Promoter)James Fan(Executive Officer, Director, Promoter)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.